![](/img/cover-not-exists.png)
Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers
Pichika, Mallikarjuna, Mai, Chun Wai, Kang, Yew BengLanguage:
english
Journal:
OncoTargets and Therapy
DOI:
10.2147/OTT.S50838
Date:
November, 2013
File:
PDF, 994 KB
english, 2013